Biodelivery Sciences International Inc (BDSI)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Mark A. Sirgo
Employees:
164
4131 PARKLAKE AVENUE, SUITE 225, RALEIGH, NC 27612
919 582 9050

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

BioDelivery Sciences International, Inc. operates as a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. It focuses on pharmaceutical products in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.

Data derived from most recent annual or quarterly report
Market Cap 577.049 Million Shares Outstanding103.229 Million Avg 30-day Volume 2.951 Million
P/E Ratio3.7734 Dividend Yield0.0 EPS0.09
Price to Revenue1.9208 Debt to Equity0.313 EBITDA44.542 Million
Price to Book Value1.7048 Operating Margin22.2695 Enterprise Value264.7 Million
Current Ratio2.453 EPS Growth2.417 Quick Ratio2.078
1 Yr BETA -0.0253 52-week High/Low 5.62 / 2.5 Profit Margin50.9049
Operating Cash Flow Growth64.2728 Altman Z-Score1.6339 Free Cash Flow to Firm 49.148 Million
View SEC Filings from BDSI instead.

View recent insider trading info

Funds Holding BDSI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BDSI BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-03-22:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2022-02-15:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-14:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-20:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-21:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-21:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-09-27:
    Item 8.01: Other Events
  • 8-K: filed on 2021-09-21:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2021-09-09:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SIRGO MARK A

    • Director
    0 2022-03-22 8

    GREENLEAF PETER

    • Director
    0 2022-03-22 3

    DAVIS TODD C

    • Director
    0 2022-03-22 3

    BAILEY JEFFREY ALLEN CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    0 2022-03-22 5

    KOTLER KEVIN

    BROADFIN CAPITAL, LLC

    BROADFIN HEALTHCARE MASTER FUND LTD

    • Director
    0 2022-03-22 7

    GOLUBIESKI JOHN SEE REMARKS

    • Officer
    0 2022-03-22 3

    WATSON W. MARK

    • Director
    0 2022-03-22 3

    PLESHA SCOTT M. SEE REMARKS

    • Officer
    0 2022-03-22 2

    SMITH THOMAS B CHIEF MEDICAL OFFICER

    • Officer
    0 2022-03-22 2

    VOLLINS JAMES SEE REMARKS

    • Officer
    0 2022-03-22 4

    SINGH VANILA

    • Director
    0 2022-03-22 5

    COELHO MARY THERESA SEE REMARKS

    • Officer
    30,619 2021-01-29 0

    ODONNELL FRANCIS E JR

    • Director
    No longer subject to file 2020-05-11 0

    CUKIER HERM CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    102,447 2020-05-04 0

    DE PAOLANTONIO ERNEST ROBERT CFO, SECRETARY AND TREASURER

    • Officer
    140,548 2018-12-04 0

    SEARS SAMUEL P JR

    • Director
    82,863 2017-11-15 0

    STONE WILLIAM B

    • Director
    159,175 2017-08-14 0

    TYSON TIMOTHY

    • Director
    4,658 2017-08-14 0

    BRAMLAGE CHARLES

    • Director
    83,150 2017-08-14 0

    D'ALONZO THOMAS

    • Director
    161,379 2017-08-14 0

    FEINBERG BARRY I

    • Director
    98,500 2017-08-14 0

    VASISHT NIRAJ SVP & CHIEF TECHNOLOGY OFFICER

    • Officer
    272,413 2017-03-24 0

    SHEA JOHN J

    • Director
    53,305 2015-08-13 0

    FINN ANDREW L EXECUTIVE VICE PRESIDENT

    • Officer
    626,745 2015-06-15 0

    MCNULTY JAMES A SVP FINANCE & TREASURER

    • Officer
    49,399 2014-01-24 0

    POOLE WILLIAM

    • Director
    18,690 2013-08-15 0

    WARD BENNY EVP OF BUSI. & STRATEGIC DEV.

    • Officer
    0 2011-02-21 0

    ELLIOTT ASSOCIATES, L.P.

    • FORMER 10% OWNER
    No longer subject to file 2009-07-24 0

    ELLIOTT INTERNATIONAL, L.P.

    • FORMER 10% OWNER
    No longer subject to file 2009-07-24 0

    CDC IV LLC

    CDC OPERATIONS LLC

    RAMSAY DAVID RUSS

    LESCHLY JAN

    KARABELAS ARGERIS N

    • SEE REMARKS BELOW.SEE REMARKS BELOW.SEE REMARKS BELOW.SEE REMARKS BELOW.SEE REMARKS BELOW.
    No longer subject to file 2009-07-23 0

    HOPKINS CAPITAL GROUP II LLC

    • 10% Owner
    • *(SEE BELOW)
    3,465,490 2008-12-26 0

    MANNINO RAPHAEL J EXECUTIVE VP & CSO

    • Officer
    • Director
    0 2008-07-24 0

    HOPKINS CAPITAL GROUP LLC

    • 10% Owner
    • (SEE BELOW)
    3,696,523 2007-09-05 0

    ODONNELL KATHLEEN M TR IRREV TR 1 FBO FRANCIS E ODONNELL JR

    • 10% Owner
    3,914,482 2007-01-10 0

    ODONNELL KATHLEEN M

    • 10% Owner
    3,919,059 2007-01-10 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 22:15:03 UTC -0.0111 0.3311 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 21:45:03 UTC -0.0111 0.3311 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 21:15:03 UTC -0.0111 0.3311 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 20:45:03 UTC -0.0096 0.3296 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 20:15:03 UTC -0.0096 0.3296 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 19:45:03 UTC -0.0096 0.3296 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 19:15:03 UTC -0.0096 0.3296 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 18:45:03 UTC -0.0096 0.3296 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 18:15:03 UTC -0.0096 0.3296 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 17:45:03 UTC -0.0096 0.3296 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 17:15:03 UTC -0.0096 0.3296 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 16:45:04 UTC 0.0025 0.3175 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 16:15:03 UTC 0.0025 0.3175 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 15:45:03 UTC 0.0025 0.3175 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 15:15:03 UTC 0.0025 0.3175 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 14:45:04 UTC 0.07 0.25 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 14:15:03 UTC 0.07 0.25 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 13:45:03 UTC 0.07 0.25 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 13:15:04 UTC 0.07 0.25 1000000
    BIODELIVERY SCIENCES INTL BDSI 2022-03-22 12:45:03 UTC 0.07 0.25 1000000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments